All Stories

  1. Divergent humoral immune signatures in response to Klebsiella pneumoniae bacteremia
  2. A multivalent capsule vaccine protects against Klebsiella pneumoniae bloodstream infections in healthy and immunocompromised mice
  3. Differential virulence and immune recognition of Klebsiella pneumoniae O-antigen subtypes O2α and O2β
  4. A multi-valent Klebsiella pneumoniae capsule vaccine 2106
  5. A chronic Acinetobacter baumannii pneumonia model to study long-term virulence factors, antibiotic treatments, and polymicrobial infections
  6. Antibody responses in Klebsiella pneumoniae bloodstream infection: a prospective cohort study
  7. Klebsiella pneumoniae bioconjugate vaccine functional durability in mice
  8. Lung infection with classical Klebsiella pneumoniae strains establishes robust macrophage-dependent protection against heterologous reinfection
  9. A chronic murine model of pulmonaryAcinetobacter baumanniiinfection enabling the investigation of late virulence factors, long-term antibiotic treatments, and polymicrobial infections
  10. Vaccine value profile for Klebsiella pneumoniae
  11. Antibody responses inKlebsiella pneumoniaebloodstream infection: a cohort study
  12. A heptavalent O-antigen bioconjugate vaccine exhibits differential functional antibody responses against diverse Klebsiella pneumoniae isolates
  13. A heptavalent O-antigen bioconjugate vaccine exhibits differential functional antibody responses against diverseKlebsiella pneumoniaeisolates
  14. Klebsiella pneumoniae: adaptive immune landscapes and vaccine horizons
  15. Replicative Acinetobacter baumannii strains interfere with phagosomal maturation by modulating the vacuolar pH
  16. Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains of Klebsiella pneumoniae
  17. Listserv to Support Community Pediatric Clinicians During the COVID-19 Pandemic
  18. ReplicativeAcinetobacter baumanniistrains interfere with phagosomal maturation by modulating the vacuolar pH
  19. Skin Findings of Impetigo Neonatorum and Staphylococcal Scalded Skin Syndrome
  20. Capsular polysaccharide inhibits vaccine-induced O-antigen antibody binding and function across both classical and hypervirulent K2:O1 strains ofKlebsiella pneumoniae
  21. Discovery and characterization of a new class of O-linking oligosaccharyltransferases from the Moraxellaceae family
  22. Airway multidrug‐resistant organisms in a population of tracheostomy and chronic ventilator‐dependent children at a tertiary care pediatric hospital
  23. Classical and γδ T cells are each independently sufficient to establish protection against a classical strain of Klebsiella pneumoniae
  24. Differential Immune Response to Klebsiella pneumoniae O-antigen subtypes O2v1 and O2v2
  25. T cell immunity to a classical strain of Klebsiella pneumoniae
  26. Murine Respiratory Tract Infection with Classical Klebsiella pneumoniae Induces Bronchus-Associated Lymphoid Tissue
  27. Pneumococcal Empyema
  28. Practical School Algorithms for Symptomatic or SARS-CoV-2-Exposed Students Are Essential for Returning Children to In-Person Learning
  29. Development and organization of pulmonary lymphoid aggregates after Klebsiella pneumoniae infection of the murine respiratory tract
  30. An unconventional T cell population is critical for protection from repeat pulmonary infection with Klebsiella pneumoniae
  31. A murine model demonstrates capsule-independent adaptive immune protection in survivors of Klebsiella pneumoniae respiratory tract infection
  32. Appropriateness of Antibiotic Prescribing in United States Children’s Hospitals: A National Point Prevalence Survey
  33. A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae
  34. Whole-Genome Sequencing of Klebsiella pneumoniae Isolates to Track Strain Progression in a Single Patient With Recurrent Urinary Tract Infection
  35. Population Structure, Antibiotic Resistance, and Uropathogenicity of Klebsiella variicola
  36. Ureaplasma urealyticum pyelonephritis presenting with progressive dysuria, renal failure, and neurologic symptoms in an immunocompromised patient
  37. In silico discovery of small molecules that inhibit RfaH recruitment to RNA polymerase
  38. Levels of cyclic di-GMP can affect the ability of Klebsiella pneumoniae to cause lung infection
  39. Klebsiella pneumoniaeFimK Promotes Virulence in Murine Pneumonia
  40. Streptozocin-Induced Diabetic Mouse Model of Urinary Tract Infection
  41. Molecular Variations in Klebsiella pneumoniae and Escherichia coli FimH Affect Function and Pathogenesis in the Urinary Tract
  42. Utilization of an Intracellular Bacterial Community Pathway in Klebsiella pneumoniae Urinary Tract Infection and the Effects of FimK on Type 1 Pilus Expression
  43. Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection